SPRB 8-K: SEC filing

Filed with the SEC on Nov 9, 2026 · accession 0001193125-26-452707

SPRB filed a 8-K (current report) with the SEC on Nov 9, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Spruce Biosciences furnished a press release announcing its financial results for the third quarter ended September 30, 2026, along with corporate updates.

For details, click here →How to read a 8-K →

Key details

RegistrantSpruce Biosciences, Inc.

President and chief financial officerSamir Gharib

✦ Ask GOAX AI about this filing — what it means for SPRB, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for SPRB?

Click here

Frequently asked questions

What did SPRB file with the SEC on Nov 9, 2026?

SPRB filed a 8-K (SEC filing). Spruce Biosciences furnished a press release announcing its financial results for the third quarter ended September 30, 2026, along with corporate updates.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other SPRB SEC filings

Get alerts when SPRB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

SPRB overview SPRB analysis SPRB news Latest SEC filings